XGEN Venture
Milan, Lombardyxgenventure.com
Overview
XGEN Venture is a venture capital firm based in Milan, Italy, specializing in early-stage life sciences investments. It focuses on biotechnology, medical devices, diagnostics, and digital health. The firm was established in 2021 by the former team of Genextra, an Italian life sciences investment company. XGEN Venture invests primarily in European companies, with a significant number of portfolio companies originating from Italian research institutes. The firm's first fund, XGEN Venture Life Sciences Fund, closed in December 2024 at approximately €180 million.
Portfolio Companies
12
Website
xgenventure.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nouscom | Oct 2026 | Series D | Co-investor |
| Aptadir Therapeutics | Sep 2026 | Seed | Co-investor |
| Dialybrid S.r.l. | Sep 2026 | Series A | Lead |
| EpilepsyGTx | Dec 2025 | Series A | Lead |
| AAVantgarde Bio | Nov 2025 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?